1. Starceski PJ, Lee PAAlbright L, et al. Hypothalamic hamartomas and sexual precocity. Am J Dis Child. 1990;144:225-228.
2.
2. Feuillan PP, Jones JV, Barnes K, et al. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long-term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty. J Clin Endocrinol Metab. 1999;84:44-49.
3.
3. de Brito VN, Latronico AC, Arnhold IJ, et al. Treatment of gonadotropindependent precocious puberty due to hypothalamic hamartoma with gonadotropin releasing hormone agonist depot. Arch Dis Child. 1999;80: 231-234.
4.
4. Kornreich L, Horev G, Blaser S, et al. Central precocious puberty: evaluation by neuroimaging. Pediatr Radiol. 1995;25:7-11.
5.
5. Smith EP, Boyd J, Frank GR, et al. Estrogen resistance caused by a mutation in the estrogen receptor gene in a man. N Engl J Med. 1994;331:1056-1061.
6.
6. Frank GR. The role of estrogen in pubertal skeletal physiology: epiphyseal maturation and mineralization of the skeleton. Acta Paediatr1995;84:627-630.
7.
7. Arisaka O, Kanazawa S, Ohyama M, et al. Elevated circulating estradiol level in neonatal ovarian cyst. Arch Pediatr Adolesc Med. 1999;153:1202-1203.
9. Klein KO. Precocious puberty: Who has it? Who should be treated? (editorial). J Clin Endocrinol Metab. 1999;84:411-414.
10.
10. Rohn RD. Nipple (papilla) development in puberty: Longitudinal observations in girls. Pediatrics. 1987;79: 745-747.
11.
11. Roche AF, French NY, Davila GH. Areolar size during pubescence. Hum Biol. 1971;43:210-223.
12.
12. DiGeorge AM, Garibaldi L. Incomplete (partial) precocious development. In: Behrman RE, et al (eds): Nelson Textbook of Pediatrics, ed. 15. Philadelphia: WB Saunders, 1996, pp 1585-1587.
13.
13. Kanazawa S, Arisaka O, Hoshi M, et al. Prominent areola as an early sign of estrogen excess in precocious pseudopuberty. Clin Pediatr Endocrinol. 1999;8(suppl 12):87-89.
